Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol
2022 · Trials · 2 citations
https://doi.org/10.1186/s13063-022-06334-5